The ability of ER degraders to activate similar AIB1-driven pro-metastatic re-programming through these mechanisms may however be likely given the discordance between ER and AIB1 functions in metastatic tumors reported here. The gene discussed is NCOA3; the disease is metastatic neoplasm.